ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men

被引:110
作者
Chion, Chan K. N. K.
Doggen, Carine J. M.
Crawley, James T. B.
Lane, David A.
Rosendaal, Frits R.
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol & Hemostasis, NL-2300 RA Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Thrombosis Res Ctr, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1182/blood-2006-07-038166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand factor (VWF) mediates the tethering/adhesion of platelets at sites of vascular injury. This function depends on its multimeric size, which is controlled by ADAMTS13. We measured plasma ADAMTS13 and VWF antigen levels by enzyme-linked immunosorbent assay (ELISA) in a large population-based case-control study (Study of Myocardial Infarctions Leiden [SMILE]), consisting of 560 men with a first myocardial infarction (MI) and 646 control subjects. Although ABO blood groups influenced VWF levels, they had no influence on ADAMTS13. Furthermore, there was no relationship between plasma ADAMTS13 and VWF levels. Similar to VWF, the estimated risk of MI was increased for every quartile of ADAMTS13 when compared to the lowest quartile (odds ratio, 1.5-1.6). If confirmed, the association of ADAMTS13 with MI may suggest an unexpected mechanistic action of ADAMTS13.
引用
收藏
页码:1998 / 2000
页数:3
相关论文
共 25 条
[1]   Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex:: studies using optical tweezers [J].
Arya, M ;
Anvari, B ;
Romo, GM ;
Cruz, MA ;
Dong, JF ;
McIntire, LV ;
Moake, JL ;
López, JA .
BLOOD, 2002, 99 (11) :3971-3977
[2]   Proteolytic inactivation of ADAMTS13 by thrombin and plasmin [J].
Crawley, JTB ;
Lam, JK ;
Rance, JB ;
Mollica, LR ;
O'Donnell, JS ;
Lane, DA .
BLOOD, 2005, 105 (03) :1085-1093
[3]   C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men [J].
Doggen, CJM ;
Berckmans, RJ ;
Sturk, A ;
Cats, VM ;
Rosendaal, FR .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (05) :406-414
[4]   ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences [J].
Feys, HB ;
Liu, F ;
Dong, N ;
Pareyn, I ;
Vauterin, S ;
Vandeputte, N ;
Noppe, W ;
Ruan, C ;
Deckmyn, H ;
Vanhoorelbeke, K .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :955-962
[5]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[6]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[7]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[8]  
GILL JC, 1987, BLOOD, V69, P1691
[9]   Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction [J].
Kaikita, K. ;
Soejima, K. ;
Matsukawa, M. ;
Nakagaki, T. ;
Ogawa, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (11) :2490-2493
[10]   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura [J].
Levy, GG ;
Nichols, WC ;
Lian, EC ;
Foroud, T ;
McClintick, JN ;
McGee, BM ;
Yang, AY ;
Siemieniak, DR ;
Stark, KR ;
Gruppo, R ;
Sarode, R ;
Shurin, SB ;
Chandrasekaran, V ;
Stabler, SP ;
Sabio, H ;
Bouhassira, EE ;
Upshaw, JD ;
Ginsburg, D ;
Tsai, HM .
NATURE, 2001, 413 (6855) :488-494